1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Recombinant Proteins Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Hormones 1.2.3 Growth Factors 1.2.4 Cytokines 1.2.5 Plasma Protein Factor 1.2.6 Recombinant Metabolic Enzymes 1.2.7 Immune Checkpoint Regulators 1.2.8 Others 1.3 Market by Application 1.3.1 Global Recombinant Proteins Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Biopharmaceutical Companies 1.3.3 Academic and Research Institutes 1.3.4 Contract Research Organizations 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Recombinant Proteins Market Perspective (2016-2027) 2.2 Recombinant Proteins Growth Trends by Regions 2.2.1 Recombinant Proteins Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Recombinant Proteins Historic Market Share by Regions (2016-2021) 2.2.3 Recombinant Proteins Forecasted Market Size by Regions (2022-2027) 2.3 Recombinant Proteins Industry Dynamic 2.3.1 Recombinant Proteins Market Trends 2.3.2 Recombinant Proteins Market Drivers 2.3.3 Recombinant Proteins Market Challenges 2.3.4 Recombinant Proteins Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Recombinant Proteins Players by Revenue 3.1.1 Global Top Recombinant Proteins Players by Revenue (2016-2021) 3.1.2 Global Recombinant Proteins Revenue Market Share by Players (2016-2021) 3.2 Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Recombinant Proteins Revenue 3.4 Global Recombinant Proteins Market Concentration Ratio 3.4.1 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Recombinant Proteins Revenue in 2020 3.5 Recombinant Proteins Key Players Head office and Area Served 3.6 Key Players Recombinant Proteins Product Solution and Service 3.7 Date of Enter into Recombinant Proteins Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Recombinant Proteins Breakdown Data by Type 4.1 Global Recombinant Proteins Historic Market Size by Type (2016-2021) 4.2 Global Recombinant Proteins Forecasted Market Size by Type (2022-2027) 5 Recombinant Proteins Breakdown Data by Application 5.1 Global Recombinant Proteins Historic Market Size by Application (2016-2021) 5.2 Global Recombinant Proteins Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Recombinant Proteins Market Size (2016-2027) 6.2 North America Recombinant Proteins Market Size by Type 6.2.1 North America Recombinant Proteins Market Size by Type (2016-2021) 6.2.2 North America Recombinant Proteins Market Size by Type (2022-2027) 6.2.3 North America Recombinant Proteins Market Size by Type (2016-2027) 6.3 North America Recombinant Proteins Market Size by Application 6.3.1 North America Recombinant Proteins Market Size by Application (2016-2021) 6.3.2 North America Recombinant Proteins Market Size by Application (2022-2027) 6.3.3 North America Recombinant Proteins Market Size by Application (2016-2027) 6.4 North America Recombinant Proteins Market Size by Country 6.4.1 North America Recombinant Proteins Market Size by Country (2016-2021) 6.4.2 North America Recombinant Proteins Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Recombinant Proteins Market Size (2016-2027) 7.2 Europe Recombinant Proteins Market Size by Type 7.2.1 Europe Recombinant Proteins Market Size by Type (2016-2021) 7.2.2 Europe Recombinant Proteins Market Size by Type (2022-2027) 7.2.3 Europe Recombinant Proteins Market Size by Type (2016-2027) 7.3 Europe Recombinant Proteins Market Size by Application 7.3.1 Europe Recombinant Proteins Market Size by Application (2016-2021) 7.3.2 Europe Recombinant Proteins Market Size by Application (2022-2027) 7.3.3 Europe Recombinant Proteins Market Size by Application (2016-2027) 7.4 Europe Recombinant Proteins Market Size by Country 7.4.1 Europe Recombinant Proteins Market Size by Country (2016-2021) 7.4.2 Europe Recombinant Proteins Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Recombinant Proteins Market Size (2016-2027) 8.2 Asia-Pacific Recombinant Proteins Market Size by Type 8.2.1 Asia-Pacific Recombinant Proteins Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Recombinant Proteins Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Recombinant Proteins Market Size by Type (2016-2027) 8.3 Asia-Pacific Recombinant Proteins Market Size by Application 8.3.1 Asia-Pacific Recombinant Proteins Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Recombinant Proteins Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Recombinant Proteins Market Size by Application (2016-2027) 8.4 Asia-Pacific Recombinant Proteins Market Size by Region 8.4.1 Asia-Pacific Recombinant Proteins Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Recombinant Proteins Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Recombinant Proteins Market Size (2016-2027) 9.2 Latin America Recombinant Proteins Market Size by Type 9.2.1 Latin America Recombinant Proteins Market Size by Type (2016-2021) 9.2.2 Latin America Recombinant Proteins Market Size by Type (2022-2027) 9.2.3 Latin America Recombinant Proteins Market Size by Type (2016-2027) 9.3 Latin America Recombinant Proteins Market Size by Application 9.3.1 Latin America Recombinant Proteins Market Size by Application (2016-2021) 9.3.2 Latin America Recombinant Proteins Market Size by Application (2022-2027) 9.3.3 Latin America Recombinant Proteins Market Size by Application (2016-2027) 9.4 Latin America Recombinant Proteins Market Size by Country 9.4.1 Latin America Recombinant Proteins Market Size by Country (2016-2021) 9.4.2 Latin America Recombinant Proteins Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Recombinant Proteins Market Size (2016-2027) 10.2 Middle East & Africa Recombinant Proteins Market Size by Type 10.2.1 Middle East & Africa Recombinant Proteins Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Recombinant Proteins Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Recombinant Proteins Market Size by Type (2016-2027) 10.3 Middle East & Africa Recombinant Proteins Market Size by Application 10.3.1 Middle East & Africa Recombinant Proteins Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Recombinant Proteins Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Recombinant Proteins Market Size by Application (2016-2027) 10.4 Middle East & Africa Recombinant Proteins Market Size by Country 10.4.1 Middle East & Africa Recombinant Proteins Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Recombinant Proteins Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abcam PLC 11.1.1 Abcam PLC Company Details 11.1.2 Abcam PLC Business Overview 11.1.3 Abcam PLC Recombinant Proteins Introduction 11.1.4 Abcam PLC Revenue in Recombinant Proteins Business (2016-2021) 11.1.5 Abcam PLC Recent Development 11.2 R&D Systems 11.2.1 R&D Systems Company Details 11.2.2 R&D Systems Business Overview 11.2.3 R&D Systems Recombinant Proteins Introduction 11.2.4 R&D Systems Revenue in Recombinant Proteins Business (2016-2021) 11.2.5 R&D Systems Recent Development 11.3 Miltenyi Biotec 11.3.1 Miltenyi Biotec Company Details 11.3.2 Miltenyi Biotec Business Overview 11.3.3 Miltenyi Biotec Recombinant Proteins Introduction 11.3.4 Miltenyi Biotec Revenue in Recombinant Proteins Business (2016-2021) 11.3.5 Miltenyi Biotec Recent Development 11.4 Thermo Fisher Scientific 11.4.1 Thermo Fisher Scientific Company Details 11.4.2 Thermo Fisher Scientific Business Overview 11.4.3 Thermo Fisher Scientific Recombinant Proteins Introduction 11.4.4 Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2016-2021) 11.4.5 Thermo Fisher Scientific Recent Development 11.5 Sigma Aldrich Company 11.5.1 Sigma Aldrich Company Company Details 11.5.2 Sigma Aldrich Company Business Overview 11.5.3 Sigma Aldrich Company Recombinant Proteins Introduction 11.5.4 Sigma Aldrich Company Revenue in Recombinant Proteins Business (2016-2021) 11.5.5 Sigma Aldrich Company Recent Development 11.6 GE Healthcare 11.6.1 GE Healthcare Company Details 11.6.2 GE Healthcare Business Overview 11.6.3 GE Healthcare Recombinant Proteins Introduction 11.6.4 GE Healthcare Revenue in Recombinant Proteins Business (2016-2021) 11.6.5 GE Healthcare Recent Development 11.7 Lonza 11.7.1 Lonza Company Details 11.7.2 Lonza Business Overview 11.7.3 Lonza Recombinant Proteins Introduction 11.7.4 Lonza Revenue in Recombinant Proteins Business (2016-2021) 11.7.5 Lonza Recent Development 11.8 Merck KGaA 11.8.1 Merck KGaA Company Details 11.8.2 Merck KGaA Business Overview 11.8.3 Merck KGaA Recombinant Proteins Introduction 11.8.4 Merck KGaA Revenue in Recombinant Proteins Business (2016-2021) 11.8.5 Merck KGaA Recent Development 11.9 ProSpec Tany TechnoGene 11.9.1 ProSpec Tany TechnoGene Company Details 11.9.2 ProSpec Tany TechnoGene Business Overview 11.9.3 ProSpec Tany TechnoGene Recombinant Proteins Introduction 11.9.4 ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2016-2021) 11.9.5 ProSpec Tany TechnoGene Recent Development 11.10 Eurogentec (Kaneka Corporation) 11.10.1 Eurogentec (Kaneka Corporation) Company Details 11.10.2 Eurogentec (Kaneka Corporation) Business Overview 11.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Introduction 11.10.4 Eurogentec (Kaneka Corporation) Revenue in Recombinant Proteins Business (2016-2021) 11.10.5 Eurogentec (Kaneka Corporation) Recent Development 11.11 PeproTech 11.11.1 PeproTech Company Details 11.11.2 PeproTech Business Overview 11.11.3 PeproTech Recombinant Proteins Introduction 11.11.4 PeproTech Revenue in Recombinant Proteins Business (2016-2021) 11.11.5 PeproTech Recent Development 11.12 BPS Bioscience 11.12.1 BPS Bioscience Company Details 11.12.2 BPS Bioscience Business Overview 11.12.3 BPS Bioscience Recombinant Proteins Introduction 11.12.4 BPS Bioscience Revenue in Recombinant Proteins Business (2016-2021) 11.12.5 BPS Bioscience Recent Development 11.13 Reprocell 11.13.1 Reprocell Company Details 11.13.2 Reprocell Business Overview 11.13.3 Reprocell Recombinant Proteins Introduction 11.13.4 Reprocell Revenue in Recombinant Proteins Business (2016-2021) 11.13.5 Reprocell Recent Development 11.14 GenScript Biotech Corporation 11.14.1 GenScript Biotech Corporation Company Details 11.14.2 GenScript Biotech Corporation Business Overview 11.14.3 GenScript Biotech Corporation Recombinant Proteins Introduction 11.14.4 GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2016-2021) 11.14.5 GenScript Biotech Corporation Recent Development 11.15 Abnova Corporation 11.15.1 Abnova Corporation Company Details 11.15.2 Abnova Corporation Business Overview 11.15.3 Abnova Corporation Recombinant Proteins Introduction 11.15.4 Abnova Corporation Revenue in Recombinant Proteins Business (2016-2021) 11.15.5 Abnova Corporation Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Recombinant Proteins Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Hormones Table 3. Key Players of Growth Factors Table 4. Key Players of Cytokines Table 5. Key Players of Plasma Protein Factor Table 6. Key Players of Recombinant Metabolic Enzymes Table 7. Key Players of Immune Checkpoint Regulators Table 8. Key Players of Others Table 9. Global Recombinant Proteins Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Recombinant Proteins Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Recombinant Proteins Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Recombinant Proteins Market Share by Regions (2016-2021) Table 13. Global Recombinant Proteins Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Recombinant Proteins Market Share by Regions (2022-2027) Table 15. Recombinant Proteins Market Trends Table 16. Recombinant Proteins Market Drivers Table 17. Recombinant Proteins Market Challenges Table 18. Recombinant Proteins Market Restraints Table 19. Global Recombinant Proteins Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Recombinant Proteins Market Share by Players (2016-2021) Table 21. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Proteins as of 2020) Table 22. Ranking of Global Top Recombinant Proteins Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Recombinant Proteins Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Recombinant Proteins Product Solution and Service Table 26. Date of Enter into Recombinant Proteins Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Recombinant Proteins Market Size by Type (2016-2021) (US$ Million) Table 29. Global Recombinant Proteins Revenue Market Share by Type (2016-2021) Table 30. Global Recombinant Proteins Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Recombinant Proteins Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Recombinant Proteins Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Recombinant Proteins Revenue Market Share by Application (2016-2021) Table 34. Global Recombinant Proteins Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Recombinant Proteins Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Recombinant Proteins Market Size by Type (2016-2021) (US$ Million) Table 37. North America Recombinant Proteins Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Recombinant Proteins Market Size by Application (2016-2021) (US$ Million) Table 39. North America Recombinant Proteins Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Recombinant Proteins Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Recombinant Proteins Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Recombinant Proteins Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Recombinant Proteins Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Recombinant Proteins Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Recombinant Proteins Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Recombinant Proteins Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Recombinant Proteins Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Recombinant Proteins Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Recombinant Proteins Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Recombinant Proteins Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Recombinant Proteins Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Recombinant Proteins Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Recombinant Proteins Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Recombinant Proteins Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Recombinant Proteins Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Recombinant Proteins Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Recombinant Proteins Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Recombinant Proteins Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Recombinant Proteins Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Recombinant Proteins Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Recombinant Proteins Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Recombinant Proteins Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Recombinant Proteins Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Recombinant Proteins Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Recombinant Proteins Market Size by Country (2022-2027) & (US$ Million) Table 66. Abcam PLC Company Details Table 67. Abcam PLC Business Overview Table 68. Abcam PLC Recombinant Proteins Product Table 69. Abcam PLC Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 70. Abcam PLC Recent Development Table 71. R&D Systems Company Details Table 72. R&D Systems Business Overview Table 73. R&D Systems Recombinant Proteins Product Table 74. R&D Systems Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 75. R&D Systems Recent Development Table 76. Miltenyi Biotec Company Details Table 77. Miltenyi Biotec Business Overview Table 78. Miltenyi Biotec Recombinant Proteins Product Table 79. Miltenyi Biotec Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 80. Miltenyi Biotec Recent Development Table 81. Thermo Fisher Scientific Company Details Table 82. Thermo Fisher Scientific Business Overview Table 83. Thermo Fisher Scientific Recombinant Proteins Product Table 84. Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 85. Thermo Fisher Scientific Recent Development Table 86. Sigma Aldrich Company Company Details Table 87. Sigma Aldrich Company Business Overview Table 88. Sigma Aldrich Company Recombinant Proteins Product Table 89. Sigma Aldrich Company Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 90. Sigma Aldrich Company Recent Development Table 91. GE Healthcare Company Details Table 92. GE Healthcare Business Overview Table 93. GE Healthcare Recombinant Proteins Product Table 94. GE Healthcare Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 95. GE Healthcare Recent Development Table 96. Lonza Company Details Table 97. Lonza Business Overview Table 98. Lonza Recombinant Proteins Product Table 99. Lonza Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 100. Lonza Recent Development Table 101. Merck KGaA Company Details Table 102. Merck KGaA Business Overview Table 103. Merck KGaA Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 104. Merck KGaA Recent Development Table 105. ProSpec Tany TechnoGene Company Details Table 106. ProSpec Tany TechnoGene Business Overview Table 107. ProSpec Tany TechnoGene Recombinant Proteins Product Table 108. ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 109. ProSpec Tany TechnoGene Recent Development Table 110. Eurogentec (Kaneka Corporation) Company Details Table 111. Eurogentec (Kaneka Corporation) Business Overview Table 112. Eurogentec (Kaneka Corporation) Recombinant Proteins Product Table 113. Eurogentec (Kaneka Corporation) Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 114. Eurogentec (Kaneka Corporation) Recent Development Table 115. PeproTech Company Details Table 116. PeproTech Business Overview Table 117. PeproTech Recombinant Proteins Product Table 118. PeproTech Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 119. PeproTech Recent Development Table 120. BPS Bioscience Company Details Table 121. BPS Bioscience Business Overview Table 122. BPS Bioscience Recombinant Proteins Product Table 123. BPS Bioscience Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 124. BPS Bioscience Recent Development Table 125. Reprocell Company Details Table 126. Reprocell Business Overview Table 127. Reprocell Recombinant Proteins Product Table 128. Reprocell Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 129. Reprocell Recent Development Table 130. GenScript Biotech Corporation Company Details Table 131. GenScript Biotech Corporation Business Overview Table 132. GenScript Biotech Corporation Recombinant Proteins Product Table 133. GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 134. GenScript Biotech Corporation Recent Development Table 135. Abnova Corporation Company Details Table 136. Abnova Corporation Business Overview Table 137. Abnova Corporation Recombinant Proteins Product Table 138. Abnova Corporation Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million) Table 139. Abnova Corporation Recent Development Table 140. Research Programs/Design for This Report Table 141. Key Data Information from Secondary Sources Table 142. Key Data Information from Primary Sources List of Figures Figure 1. Global Recombinant Proteins Market Share by Type: 2020 VS 2027 Figure 2. Hormones Features Figure 3. Growth Factors Features Figure 4. Cytokines Features Figure 5. Plasma Protein Factor Features Figure 6. Recombinant Metabolic Enzymes Features Figure 7. Immune Checkpoint Regulators Features Figure 8. Others Features Figure 9. Global Recombinant Proteins Market Share by Application: 2020 VS 2027 Figure 10. Biopharmaceutical Companies Case Studies Figure 11. Academic and Research Institutes Case Studies Figure 12. Contract Research Organizations Case Studies Figure 13. Recombinant Proteins Report Years Considered Figure 14. Global Recombinant Proteins Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Recombinant Proteins Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Recombinant Proteins Market Share by Regions: 2020 VS 2027 Figure 17. Global Recombinant Proteins Market Share by Regions (2022-2027) Figure 18. Global Recombinant Proteins Market Share by Players in 2020 Figure 19. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Proteins as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Recombinant Proteins Revenue in 2020 Figure 21. Global Recombinant Proteins Revenue Market Share by Type (2016-2021) Figure 22. Global Recombinant Proteins Revenue Market Share by Type (2022-2027) Figure 23. North America Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Recombinant Proteins Market Share by Type (2016-2027) Figure 25. North America Recombinant Proteins Market Share by Application (2016-2027) Figure 26. North America Recombinant Proteins Market Share by Country (2016-2027) Figure 27. United States Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Recombinant Proteins Market Share by Type (2016-2027) Figure 31. Europe Recombinant Proteins Market Share by Application (2016-2027) Figure 32. Europe Recombinant Proteins Market Share by Country (2016-2027) Figure 33. Germany Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Recombinant Proteins Market Share by Type (2016-2027) Figure 41. Asia-Pacific Recombinant Proteins Market Share by Application (2016-2027) Figure 42. Asia-Pacific Recombinant Proteins Market Share by Region (2016-2027) Figure 43. China Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Recombinant Proteins Market Share by Type (2016-2027) Figure 51. Latin America Recombinant Proteins Market Share by Application (2016-2027) Figure 52. Latin America Recombinant Proteins Market Share by Country (2016-2027) Figure 53. Mexico Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Recombinant Proteins Market Share by Type (2016-2027) Figure 57. Middle East & Africa Recombinant Proteins Market Share by Application (2016-2027) Figure 58. Middle East & Africa Recombinant Proteins Market Share by Country (2016-2027) Figure 59. Turkey Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Abcam PLC Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 63. R&D Systems Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 64. Miltenyi Biotec Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 66. Sigma Aldrich Company Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 67. GE Healthcare Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 68. Lonza Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 69. Merck KGaA Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 70. ProSpec Tany TechnoGene Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 71. Eurogentec (Kaneka Corporation) Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 72. PeproTech Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 73. BPS Bioscience Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 74. Reprocell Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 75. GenScript Biotech Corporation Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 76. Abnova Corporation Revenue Growth Rate in Recombinant Proteins Business (2016-2021) Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed

Abcam PLC R&D Systems Miltenyi Biotec Thermo Fisher Scientific Sigma Aldrich Company GE Healthcare Lonza Merck KGaA ProSpec Tany TechnoGene Eurogentec (Kaneka Corporation) PeproTech BPS Bioscience Reprocell GenScript Biotech Corporation Abnova Corporation